RxSight Newsroom

Stifel Downgrades RxSight to Hold, Lowers Price Target to $40

BenzingaDec 20 18:55

Wells Fargo Downgrades RxSight(RXST.US) to Hold Rating, Cuts Target Price to $42

Futu NewsDec 11 19:32

RxSight Analyst Ratings

BenzingaDec 6 20:55

UBS Maintains RxSight(RXST.US) With Buy Rating, Raises Target Price to $52

Futu NewsDec 6 18:34

RxSight's Promising Growth With Light Adjustable Lens: A Buy Recommendation by Danielle Antalffy

TipRanksDec 6 18:19

Morgan Stanley Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $70

Futu NewsNov 11 21:37

BofA Securities Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $60

Futu NewsNov 8 23:32

Stifel Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $65

Futu NewsNov 8 23:32

Wells Fargo Maintains RxSight(RXST.US) With Buy Rating, Raises Target Price to $56

Futu NewsNov 8 20:31

BofA Securities Maintains RxSight(RXST.US) With Buy Rating, Cuts Target Price to $60

Futu NewsNov 8 18:36

Needham Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $66

Futu NewsNov 8 18:33

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Artivion (AORT) and RxSight (RXST)

TipRanksNov 8 18:22

RxSight's Strong Growth and Market Positioning Earns Buy Rating From Analyst

TipRanksNov 8 17:53

RxSight Analyst Ratings

BenzingaOct 29 19:52

Jefferies Initiates RxSight(RXST.US) With Buy Rating, Announces Target Price $72

Futu NewsOct 29 17:32

BTIG Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $59

Futu NewsSep 23 18:31

Needham Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $66

Futu NewsSep 13 19:33

RxSight's Growth Trajectory: A Buy Recommendation on Strong Revenue Prospects and International Expansion

TipRanksSep 13 18:38

Morgan Stanley Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $70

Futu NewsSep 5 19:34

Needham Maintains Buy on RxSight, Raises Price Target to $66

BenzingaAug 21 00:27